Lilly signs $2.25B deal with California-based AI firm to develop genetic medicine

Please subscribe to IBJ to decode this article.

mceeal aa orC 2 mutihrmlelfttr enshsioniotieopa nntddiatish li2ittirbn ribtEei. e iiLid el laieieCgssa eali.gpngeb.$tct tdolgiakyo -fllnc co,atfiiarrelnihiw5 nos ohtlof

esndesrel bna rgse ee r fosPlop .rear Ikirtnlfoselomh g fidfm npamu-lnotiem teuAeoasgs cdmgrourewiao bute.ip siaen“hee ieenr enoenlsetrlevpn s o e daesf slwcaftiotPectz i ieie drd acralpdlodlmriay Iercroioipdatnis thdn mtwno”dvtTiuf enaensttnnaa-ersr

touaern nctt.meyotfeN tunDwcsikeA inc myye liaabet ks PdsrLt wusefialilsae sehatz chcirp m rneincaot caao slainis htt ndglaeit,repo in hc farT heor-cudciwo nlaw e

iopnaetmiepncg ohoginaeitttlcD fdvsblan eoe atrci.-l gl .pnstahtLgna-raf lPusrsic edresni-e c a iutyndftreiieaaT rnwxb onn slltPftd lAcei fu etgeto ianioeanoa tg nr,e,s aeeonlpdta nhaeetlcdnolhs mNineioipp y s rcbau lh inistedolnmsygoce eil coapui eecuc nieggs

eha nlouds rAmoel a Mr ititemtea ew fi tsn ocnncani.ul-ce nruvCahheoe tgi lisisgia.ennWnehheelmd cma rle Oiesed“eiodg hetrlLieelbtrbotak litnidc-ryiit esneeynaiinnoysa lum otoue e sdeaoce l iwrac eep ninvsiuA anadhslsheoneglie ”O bI ctpaeulaKrdi,eogw oyndssiibief” otci.Pl AEtreorN tn cyrkD“ngpac s gy ni rdeges mteli atsapre a eoe

t nlcn aftTgro eIle, droi see s aiclgalesgplmenccneerr naam e evoae sbweisrdezn aiatng ,lcl sesmi wcyitb -oco eheea lettrisrtsoildvP.etrst nnc me fdemscercawv tmpwiei linaiefomn slocugelcteilipduiblifacr ss tonimeoienh lvimheooiaanolouovnr ,ehAa r c iluihLrlitcdhueeoe

n rwn e 2seiL el cnlodAloinenssi rdytvultkngln eatee ead atm ae.ieiseaumit tmleros iy$tten vlptg5oe eaoelmeacscd lflei.pndotrips,a pioac onrttcdieiil yddbtosama. ma2w Pfc myidnloeole nei olymirlee restpeiuedf lnnn att hos n

deiin oadof.xsxotlea2idruu-stpl cesCzuai0anz Eoersem t vfianuecdBnnvr e ni eerntnfsueoflodaaietdi hntrTf Ada i uh1gsJeBaa,rdonk ehisream ynint Pdnrdgngvao,lr fi$ f lntnfc epd ooilei ro o zarc ll e lnym onevsofEAeeemi ueb.l sdhporpfoaMw2d6hM t,ehn,r setunn mhmeieP-lNdlfoinbin2 f0emo

iy elitebLTdoub llnladwahneio y ere ittgsi i rroo cbeaasnaleoPgsne eo.frcmdash-msrttietsah cseehnn h

bsc.t-rpieioe,a$a-dleet n rl ntneme-onas-s h2ungatmhafGl/-dhatm d dyt/lgilfblsi2-eres sas,=e mrloi1ebemcaIllco s-laaeiLeetfsrnootdmo-otahnwrsrs- p-1 et .athyr"Sbetu sre1tedo/wrvDipi .tncitsosi wmnyiwa ohforsdwe ep r r"1e h lgarl/revalsguuezao:Jbiitr e e.e p-lcne>agag’ei-i mtctnmehyi

ngsv y hact,stt istreeighyn prgsTsagdbsogoeli hdme tleu ilaetr .’e erlyroeampaeccm as toil ctdatoLoo slirorpShn rebmhnusallsoesoarh al e lthaatew e ee

Tdpg mes tnabhSo dhomnl niaeiaeyarchsaems eietpels nelts n hst a rt .dc snee unsaPalsiecerLe snshrweusrbiri iodt tedesnhig ihifhltef o iawipeit allalseturp teeap ef

iLlnyaly I.eeuol tdlo-c-svle lo, snaiannpe dlrt/oe/rpei/l:f.ertdB i ugi lsr cnncniotqd /da"/attayBaucTeuwelio gdp p1$caute-ort> al-l-uoe caabif-raloietlptc1le:aivtfsaipamnAd hduhmes . >vaihs-eoydo aveci iaataodaoe r-l s-nng odeigsdbjV,-af ytnsercaqsedtnp"soecTfhiegreorcilveL voiiyiplrc/cv, ertun-wsmg.=.ofpoCs"-lbao ridnnsaf cmy

ss.c=eea--72nj n iittI./nc ldat.ar7fkii .olooo iuAhhp otrdrqnna$fo0 yaisnnse ppnlie ocsye a4>mnf,ygt/oevota-"twi-w g4ga ber otIslueia prlhst:culec",teeoeromabrf-tmi8q slp/2aalrc oec-eo

em.2hs%rl yne$s ea e486 hyO .ned6o sraowdannigLcinnr e laWr w5lody, et